LOSS PER SHARE (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2024

Dec. 31, 2023

Earnings Per Share [Abstract]

SCHEDULE OF EARNINGS PER SHARE ANTI DILUTIVE

	June 30, 2024		June 30, 2023
Series A Preferred Stock		139,790,000		-
Series B Preferred stock (1)		-		147,013,500
Series C Preferred Stock (2)		-		7,010,000
Restricted Stock Awards		-		5,005,000
Convertible Notes		-		127,031,864
Warrants		55,922,119		108,734
Total common stock equivalents		195,712,119		286,169,098

(1)

On January 10, 2024, the Company redomiciled and its pre-existing Series A class of Preferred Stock and Series B class of Preferred stock were eliminated (Note 1 – Organization and Nature of Operations). The Statement of Changes in Stockholders’ Equity/Member’s Equity for the three and six months ended June 30, 2024 has been retrospectively restated to reflect these changes.

(2)

On January 10, 2024, the Company redomiciled and exchanged all outstanding shares of its pre-existing Series C Preferred Stock for shares of a new class of Series A Preferred Stock (Note 1 – Organization and Nature of Operations). The Statement of Changes in Stockholders’ Equity/Member’s Equity for the three and six months ended June 30, 2024 has been retrospectively restated to reflect this change.

	Year Ended		Year Ended
	December 31,		December 31,
	2023		2022
Series C preferred stock		63,090,000		-
Warrants		2,608,734		-
Total common stock equivalents		65,698,734		-